New COVID vaccine trial shows promise for all ages
NCT ID NCT04869592
First seen Jan 18, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study tested a new COVID-19 vaccine made using CHO cells in healthy people aged 3 and older. About 3100 participants received either the vaccine or a placebo to check safety and immune response. The goal was to find the best dose and schedule for different age groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ning ling Center for Disease Control and Prevention
Shangqiu, Henan, China
Conditions
Explore the condition pages connected to this study.